Biosensors   

Is Biosensors a good buy?

Best time to push is NOW so that when the mkt recovers, you get a double bonus.  Cheers.

 

Yes it moves only on news and news only (regardles of mkt sentiments).... something MUST be brewing

 

STI drop>50 pts due to weak Dow and consumer spending but Biosensor after initial fear,now evergreen again.
This time is for REAL


From nibble to srong buy or accumulate unlikley will test 55cts again,limited downside but upside is favourable.

Noted..BIG cannpt contra mjust hve patience/.

Biz times 17 Aug rept they are palnning Biomatrix_Drug Eluting Stent sale to France,Korea,Taiwan,PRC-its 50% PRC subsidiary contribute graetly to its bottom line-can wait since acquire quite cheap[/quote]Not to worry end of day sure push back to 60cts or higher

 

short covering become long position,,,,,,,,,,,,,,,,repeat again,,,,,,,,,,,,,same group

 

shortist kenna catch short,,,,,,,,,,,,,,,,,dun know they close their position or not,,,,,,,,,,,,,

 

biosensor wanna laund product to more market,,,,,,,,,,,,,latest news,,,,,,,,,,,,,,,,so price sure moving,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,but im prefer tis baby do their job on china,,,,japan,,,,,,,,,europre and usa,,,,,,,,,,,,,,,,,,hight profile against other giant riv company,,,,,,,,,,,,,,,dun open too many market very hard fight with other gian...at least now they dun have huge resourse to fight for long lasting war,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disappointed

 

DUBLIN, Aug 11, 2009 (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/c8d2ab/drug_eluting_stent) has announced the addition of Global Markets Direct's new report "Drug Eluting Stent (DES) Clinical Trial Analysis" to their offering.

Global Markets Direct's " Drug Eluting Stent (DES) Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Drug Eluting Stent (DES) manufacturers, globally.

The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope: The report provides analysis and review of the key clinical trials being carried out globally and across key Drug Eluting Stent (DES) market categories - Drug Eluting Stent (DES) The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc. The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy: Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline. Stay ahead of the information curve in the fast changing Drug Eluting Stent (DES) market. Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies. Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline. Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Key Topics Covered: 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Drug Eluting Stent (DES) Clinical Trials 2.1 Drug Eluting Stent (DES) Clinical Trial By Equipment Type 2.2 Drug Eluting Stent (DES) Clinical Trials By Trial Phase and Trial Status 2.3 Drug Eluting Stent (DES) Pipeline Products By Development Stage 2.4 Drug Eluting Stent (DES) Pipeline Products By Therapy Area 2.5 Drug Eluting Stent (DES) Pipeline Products By News Summary 3 Recent Developments 3.1 Product News 3.2 Product Approvals 3.3 Clinical Trials 4 Appendix 4.1 Methodology 4.2 Contact Us 4.3 About us 4.4 Disclaimer For more information visit http://www.researchandmarkets.com/research/c8d2ab/drug_eluting_stent SOURCE: Research and Markets CONTACT: Research and Markets Laura Wood, Senior Manager Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 press@researchandmarkets.com Copyright Business Wire 2009 -0- KEYWORD: United States

 

Whether you rely on FA or TA... the fact of life for this counter is that it only moves on news.... 

 

The reasons for the upsurge are obvious.  The fundamentals have improved, the technicals also have been moving nicely and now showing good sign to spike.  Would probably gap up monday or if not some time during the week.  Cheong liao. Huat for all supporters who have held on  Biosensors hope too long already.

 

Next event is TCT in San Fran in Sept... where there will reveal the 2 yr reults of LEADERS  and if I'm not mistaken some results of Biomatrix Freedom trials.. Other than that I guess the other movers would be approval by the Chinese and the usual speculation about M&A..

xinyang      ( Date: 16-Aug-2009 01:07) Posted: Seems we are in the same frequency. I tried very hard to find out the answer for this but i don't figure it out. Initially scared of any BB playing this and scare it may go down very soon, but after some analysis i don't think it is a bad sign. So my guess is should be due to some good news which may unveil in near future. those insider news which the public will not know one. Just my guess only. gbleng      ( Date: 15-Aug-2009 16:19) Posted: I'm not sure current surge is due to anything relating to possible rights issue.... doubtful.... anyone can explain the upsurge happening in the last hour of trading on both thurs and friday?

 

Seems we are in the same frequency. I tried very hard to find out the answer for this but i don't figure it out. Initially scared of any BB playing this and scare it may go down very soon, but after some analysis i don't think it is a bad sign.

So my guess is should be due to some good news which may unveil in near future. those insider news which the public will not know one.

Just my guess only.

gbleng      ( Date: 15-Aug-2009 16:19) Posted: I'm not sure current surge is due to anything relating to possible rights issue.... doubtful.... anyone can explain the upsurge happening in the last hour of trading on both thurs and friday?

 

I'm not sure current surge is due to anything relating to possible rights issue.... doubtful.... anyone can explain the upsurge happening in the last hour of trading on both thurs and friday?

 

IMO:

By doing a right issues may be a good option for BIG:

1) Lower gearing ration ( lesser loan liability ).

2) If the right issues is for a strategic investment partner in the same field or from fund house, then it will be even more positive for BIG and the share price may even appreciate further after the right issues.

3) Share price may have some fair correction due to the the rights but for some, the price will appreciate even more from there onward if the rights is deemed accepted as a strategic move. Eg. NOL. Look at how NOL move after the rights .....  

4) If the rights are very much accepted and subscribed  .... then it even bores well for BIG as this signals the confidence level the investors had in BIG.

4) BIG is now already in the BLACK ... furthermore, the mgmt already mentioned that the profits will weighed more towards the 2nd half of FY10 .. so surprises maybe well on the way ....

Barring any unforseen situation, i will still hold on to it and wait for the right issues and stick with BIG till this FY10 close. Reasons: Upside is till there ....

Cheers.

Above is not an inducement to trade.

 

RECENTLYWHEN COY ANN RIGHT ISSUE SHARE PRICE WILL SHOT UP BUT NOW SO MANY COY ANYHOW RIGHT ISSUE,,,,,,,,,SO IT WAS ABOUT THE TIME RIGHT ISSUE WILL CREATE BECOME POISON,,,,,,,,,,,,,,SHRE WILL DOWN AFTER RIGHT ANN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,SO TIME ALRADY RUNNING OUT,,,,,,,,,,,,,,DRY OUT,,,,,,,,,,,,,,,,,,,,,,,,,FOR TIS BABY,,,,,,,,,,,,,,,,,,,BETTER DUN DO RIGHT ISSUE,,,,,,,,,,,,,AT LEAQST NOW SO MANY RIGHT FLOOD INTO MARKET,,,,,,,,,,,,,,,,,,,,,,CAPITAL ALMOST DRY OUT...............................

 

BECAREFULL THE FINAL WAVE RALLY ,,,,,,,,,,,,,,,AFTER 9MONTH RALLY,,,,,,,,,,,,,,,,BOND STILL NOT SETTLE NOW NOV IS NEAR,,,,,,,,,,,,,,,,,,,,,,

 

Fri Aug 14, 2009 5:23 pm    Post subject:
shinkei wrote: Cup and Handle formation.. Broke up above 0.60 cents Good luck to those vested.. Huat Cai loe U'll be surpise when touch new high will go even higher esp in a bull run..U know it has been consolidating between 48-58.5cts from May -Aug 13...60cts just 6cts above yr 54cts lah at 59cts I bought another 50lots this morning to add to my existing holding. Fri Aug 14, 2009 5:03 pm Post subject: Finally Touched 60cts high was 61cts on a friday aug 14 -------------------------------------------------------------------------------- paulricoeur wrote: What's going on? Don't think it is announceing new test result- that will be in September Will there be some fund raising exercise where share hloders will be rewarded? Can touch 2009's high on a Friday with high vol is an encouraging sign-probably pushing to catch up with STI and Biosensor has been languishing <ipo of 70cts and now that Co has turn around with expoential sale mainly from Bio-matrix and its clinical results can match even big name like Johnson& Johnson...previously in the red can be $1.22-$1.50 and as recently as 1-2 years ago was 70cts to $1.10.now the time to reward shareholders esp those who holding since 2005- : chensing View Public Profile Send a private message to chensing Find More Posts by chensing Add chensing to Your Buddy List Today, 04:56 PM #4 juuzbe Member Join Date: Aug 2008 Posts: 187 aiya.. but now enter like too late liao lah.. when 0.545 recently me still pondering.. sigh! juuzbe View Public Profile Send a private message to juuzbe Find More Posts by juuzbe Add juuzbe to Your Buddy List Ads By Google Singapore Divorce Lawyers Specialises in Non-Contentious and Contentious Matrimonial Matters. www.aajpLaw.com/Divorce Dr Ivan Puah Vaser LipoSelection ® Pioneer Cosmetic Surgeon in Singapore. www.amaris-b.com/body_b.html Today, 04:51 PM #3 MikeL09 Junior Member Join Date: May 2009 Posts: 78 This counter seemed to have benefited from the Daiwa report. In fact, it was moving so fast after that report that I was prompted to call up a former colleague who works there to hear first hand if BioMatrix is selling well among local cardiologists/ hospitals, if not, how they're doing in the regional markets. This is one counter I regretted not going in earlier when it was selling at 40 plus cts. Now, I can

 

Finally cross 60cts after testing 58.5-59cts,funny only 2 postings despite BIG moving finally-probably many sold off liao-gd sign again.Suspect thsi push may be for pte placement,probably to provide > working capital and retire the USD 45mil due soon..any better suggestion

 

Even with less profits than .75, Uncle AK and all the supporters can go for  "Yaaaaaaaaaaarrrrrrmmmm...Seng!!! ... hehehe...

 

Ha ha, no need 75, 5 cts less also jadi liao. Cheers for all d supporters since mths ago.

investor      ( Date: 13-Aug-2009 22:25) Posted: Daiwa Securities initiate coverage with a buy call, target price 0.75 cents.  on 12 Aug - Report circulated today, since this morning.

 

Last tested 58.5cts was on May 29 2009...vroom..vroom turnaround co-recent AGM-mgt may do something to raise more $$$ to repay convertible loan of USD 45mil although current cash balance and future proceed may be > than sufficient-suspect co may push up share price to do pte placement

investor      ( Date: 13-Aug-2009 22:25) Posted: Daiwa Securities initiate coverage with a buy call, target price 0.75 cents.  on 12 Aug - Report circulated today, since this morning.